Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Post by general360on Aug 21, 2020 11:17am
262 Views
Post# 31438414

off topic, but should be on topic: inflammation/covid

off topic, but should be on topic: inflammation/covid
if only we had a positive effect on ACE2, cytokines, inflammation and the inflammatory response! man, id be dreaming in $$$  if we were able to come up with a small molecule pill that would do allllllllllll that, and then some!!

i know, lets talk about it, sit on it for 6 months and DO NOTHING!!!!  we're about 6+mo into COVID and NOTHING. NADA.  CONE OF SILENCE.

data data data, lets do nothing but sit on that too!  thats only 10+ months!

AAPL YTD alone, 67% ROE.............. now if i held AAPL over this same time period as RVX, where would i be???? +300%?  >400%?   NOT DOWN +70%.    ENRAGING!!!!!!!!!!!!!!

Inflammation: The key factor that explains vulnerability to severe COVID

<< Previous
Bullboard Posts
Next >>